CompletedNot Applicable

The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in Adults

Singapore263 participantsStarted 2022-04-12

Plain-language summary

The goal of this randomised controlled trial is to determine the effectiveness of topical sesame oil in preventing phlebitis at peripheral intravenous (IV) cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital. The main question it aims to answer is: Is topical sesame oil effective in preventing phlebitis at peripheral IV cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital? Participants will be randomly allocated to the experimental or control group with the use of a randomisation software (MS excel). They will each have five drops/0.25mls of 100% sesame oil (experimental) or liquid paraffin oil (control) applied to the IV cannula site, at 12 hourly intervals for a total of 72 hours, from 3cm above the insertion point to 10cm along the vein, with a width of 2cm on either side. Researchers will compare the phlebitis incidence and severity of each group to see if topical sesame oil is more effective than liquid paraffin oil in preventing phlebitis at IV cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital.

Who can participate

Age range21 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 21-80 * Patients must speak and understand either English or Mandarin * Patients who possess a peripheral IV cannula * IV cannula must have been inserted for less than 12 hours * IV cannula must be on an upper extremity * IV cannula must be patent * IV cannula sites must show no signs of redness, swelling, pain, a palpable venous cord or pyrexia * Patient must be admitted to a cardiology ward in the National Heart Centre Singapore Exclusion Criteria: * Patients who do not speak or understand either English or Mandarin * Patients with venous insufficiency * Patients with coagulopathies * Patients with cognitive or sensory impairments that would inhibit their ability to rate their pain via a Numerical Rating Scale (NRS) * Patients who are receiving medications that might interfere with timely reporting of adverse events (eg. medications that cause severe drowsiness) * Patients who report allergies to sesame or liquid paraffin oil * IV cannulas that were inserted and used for resuscitation * Patients with existing skin conditions that cause their skin to be red or swollen and might affect the investigators ability to assess for phlebitis * Patients who possess more than one peripheral IV cannula will only be included in the study once. All subsequent IV cannula insertions will be excluded.

What they're measuring

Phlebitis incidence

Timeframe: At 12 hourly intervals for a total of 72 hours

Trial details

NCT IDNCT06216522

SponsorNational Heart Centre Singapore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-21